115 related articles for article (PubMed ID: 7688611)
1. [The outlook for the clinical use of recombinant cytokines].
Ketlinskiĭ SA
Vestn Ross Akad Med Nauk; 1993; (2):11-8. PubMed ID: 7688611
[No Abstract] [Full Text] [Related]
2. The impact of cytokines on high dose chemotherapy followed by transplantation of purified and ex vivo expanded peripheral blood stem cells: achieving a state of minimal residual disease for tumor immunotherapy with cytokine gene transfected cells.
Mertelsmann R
Eur Cytokine Netw; 1995; 6(2):79-82. PubMed ID: 7578991
[No Abstract] [Full Text] [Related]
3. Role of cytokines in autologous bone marrow transplantation.
Peters WP; Ross M; Vredenburgh J; Hussein A; Meisenberg B; Gilbert C; Petros WP; Kurtzberg J
Hematol Oncol Clin North Am; 1993 Jun; 7(3):737-47. PubMed ID: 8344888
[TBL] [Abstract][Full Text] [Related]
4. The present and future of hematopoietic cytokines in clinical practice.
George MJ
Stem Cells; 1994; 12 Suppl 1():249-55. PubMed ID: 7696964
[TBL] [Abstract][Full Text] [Related]
5. Biotherapy in hematology: the next decade.
Quesenberry PJ
Rev Invest Clin; 1994 Apr; Suppl():8-15. PubMed ID: 7886315
[No Abstract] [Full Text] [Related]
6. Hematopoietic growth factors in cancer chemotherapy.
Morstyn G; Foote M; Lieschke GJ
Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
[No Abstract] [Full Text] [Related]
7. Cytokine therapy of neoplastic and inflammatory disease.
Aulitzky WE; Huber C; Peschel C
Int Arch Allergy Immunol; 1993; 101(3):221-6. PubMed ID: 8324383
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokines in oncology.
Lange W; Brugger W; Rosenthal FM; Kanz L; Lindemann A
Int J Cell Cloning; 1991 Jul; 9(4):252-73. PubMed ID: 1894956
[TBL] [Abstract][Full Text] [Related]
9. [Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases].
Wittig BM; Zeitz M
Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S52-8. PubMed ID: 11450615
[No Abstract] [Full Text] [Related]
10. Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies.
Fefer A; Benyunes MC; Massumoto C; Higuchi C; York A; Buckner CD; Thompson JA
Semin Oncol; 1993 Dec; 20(6 Suppl 9):41-5. PubMed ID: 8284691
[No Abstract] [Full Text] [Related]
11. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
[No Abstract] [Full Text] [Related]
12. Regional application of cytokines: experience with various clinical protocols.
Eggermont AM; Goey SH; Bolhuis RL; Stoter G
Pharmacol Res; 1992 Sep; 26 Suppl 2():54-5. PubMed ID: 1409327
[No Abstract] [Full Text] [Related]
13. Development of myelorestorative and immunotherapeutic properties of cytokines.
Talmadge JE; Bloom J; Black P; Badger A
Prog Clin Biol Res; 1990; 354A():271-85. PubMed ID: 2247492
[No Abstract] [Full Text] [Related]
14. Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 study.
Blaise D; Stoppa AM; Olive D; Brandely M; Tiberghien P; Attal M; Attal J; Reiffers J; Demeocq F; Pico JL
Bone Marrow Transplant; 1991; 7 Suppl 2():146. PubMed ID: 1878687
[No Abstract] [Full Text] [Related]
15. [Natural and recombinant interferons].
Läer S
Med Monatsschr Pharm; 1999 Nov; 22(11):340-5. PubMed ID: 10596267
[No Abstract] [Full Text] [Related]
16. Cytokines in the pathogenesis and management of non-Hodgkin's lymphomas.
Cicco NA; Lübbert M; Oster W; Lindemann A; Mertelsmann R
Hematol Oncol Clin North Am; 1991 Oct; 5(5):1053-66. PubMed ID: 1938755
[TBL] [Abstract][Full Text] [Related]
17. Marketing of recombinant granulocyte-macrophage colony-stimulating factor approved by FDA.
Clin Pharm; 1991 Jun; 10(6):411. PubMed ID: 2065520
[No Abstract] [Full Text] [Related]
18. Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation.
Slavin S; Ackerstein A; Kedar E; Reich S; Gomez S; Naparstek E; Nagler A; Or R; Weiss L
Transplant Proc; 1991 Feb; 23(1 Pt 1):802-3. PubMed ID: 1990696
[No Abstract] [Full Text] [Related]
19. [Cytokines are a new generation of biotherapeutic agents].
Ershov FI
Vestn Ross Akad Med Nauk; 2006; (9-10):45-50. PubMed ID: 17111924
[TBL] [Abstract][Full Text] [Related]
20. High efficiency targeting of IFN-α activity: possible applications in fighting tumours and infections.
Uzé G; Tavernier J
Cytokine Growth Factor Rev; 2015 Apr; 26(2):179-82. PubMed ID: 25466630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
